Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Grant/Award of 120,000 BCLI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 120,000 | n/a |
| Jan 3, 2025 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 30,666 | n/a |
| Dec 17, 2021 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 25,333 | n/a |
| Dec 10, 2021 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 25,333 | n/a |
| Feb 14, 2020 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/Award | 25,333 | n/a |